FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012256930> ?p ?o ?g. }

• W2012256930 endingPage "986" @default.
• W2012256930 startingPage "979" @default.
• W2012256930 abstract "The risk of glucocorticoid-induced osteoporosis increases substantially with age but there is considerable individual variation. In recent studies we have shown that the effects of glucocorticoids on bone are dependent on autocrine actions of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1); expression of 11beta-HSD1 in osteoblasts (OBs) facilitates local synthesis of active glucocorticoids with consequent effects on osteoblastic proliferation and differentiation. Using primary cultures of human OBs, we have now characterized the age-specific variation in osteoblastic 11beta-HSD1 and defined enzyme kinetics and regulation using natural and therapeutic glucocorticoids. 11beta-HSD1 reductase activity (cortisone to cortisol conversion) was recognized in all OB cultures and correlated positively with age (r = 0.58 with all cultures, p < 0.01, and n = 18; r = 0.87 with calcaneal-derived cultures, p < 0.001, and n = 14). Glucocorticoid treatment caused a time- and dose-dependent increase in 11beta-HSD1 activity over control (e.g., dexamethasone [DEX; 1 microM], 2.6-fold +/- 0.5 (mean +/- SE), p < 0.001, and n = 16; cortisol (100 nM), 1.7-fold +/- 0.1, p < 0.05, and n = 14). Similar increases in 11beta-HSD1 mRNA expression were indicated using real-time quantitative reverse-transcription polymerase chain reaction (RT-PCR) analyses (3.5-fold with DEX, p < 0.01; 2.5-fold with cortisol, p < 0.05). The capacity of 11beta-HSD1 to metabolize the synthetic glucocorticoids prednisone and prednisolone was investigated in human OBs (hOBs) and fetal kidney-293 cells stably transfected with human 11beta-HSD1 cDNA. Transfected cells and hOBs were able to interconvert prednisone and prednisolone with reaction kinetics indistinguishable from those for cortisone and cortisol. To assess the in vivo availability of substrates for osteoblastic 11beta-HSD1, plasma cortisone and prednisone levels were measured in normal males before and after oral prednisolone (5 mg). The 9:00 a.m. serum cortisone levels were 110 +/- 5 nmol/liter and prednisone levels peaked at 78 +/- 23 nmol/liter 120 minutes after administration of prednisolone. Thus, therapeutic use of steroids increases substrate availability for 11beta-HSD1 in bone. These studies indicate that activation of glucocorticoids at an autocrine level within bone is likely to play an important role in the age-related decrease in bone formation and increased risk of glucocorticoid-induced osteoporosis." @default.
• W2012256930 created "2016-06-24" @default.
• W2012256930 creator A5030709787 @default.
• W2012256930 creator A5034358714 @default.
• W2012256930 creator A5039317852 @default.
• W2012256930 creator A5049986054 @default.
• W2012256930 creator A5050877182 @default.
• W2012256930 creator A5055574817 @default.
• W2012256930 date "2002-06-01" @default.
• W2012256930 modified "2023-10-10" @default.
• W2012256930 title "Osteoblastic 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure" @default.
• W2012256930 cites W1570147293 @default.
• W2012256930 cites W1963597760 @default.
• W2012256930 cites W1972567404 @default.
• W2012256930 cites W1980418071 @default.
• W2012256930 cites W1987354827 @default.
• W2012256930 cites W1987840607 @default.
• W2012256930 cites W1988721679 @default.
• W2012256930 cites W1990370190 @default.
• W2012256930 cites W2000868930 @default.
• W2012256930 cites W2001635405 @default.
• W2012256930 cites W2003466615 @default.
• W2012256930 cites W2012957985 @default.
• W2012256930 cites W2015620080 @default.
• W2012256930 cites W2016881895 @default.
• W2012256930 cites W2017417924 @default.
• W2012256930 cites W2024811700 @default.
• W2012256930 cites W2042443117 @default.
• W2012256930 cites W2045947279 @default.
• W2012256930 cites W2056748720 @default.
• W2012256930 cites W2058915859 @default.
• W2012256930 cites W2089750948 @default.
• W2012256930 cites W2091404074 @default.
• W2012256930 cites W2117268230 @default.
• W2012256930 cites W2129546749 @default.
• W2012256930 cites W2131751497 @default.
• W2012256930 cites W2148328115 @default.
• W2012256930 cites W2168871075 @default.
• W2012256930 cites W2185954894 @default.
• W2012256930 cites W2314674563 @default.
• W2012256930 cites W2335475908 @default.
• W2012256930 cites W2411901845 @default.
• W2012256930 cites W4214906399 @default.
• W2012256930 cites W4234503248 @default.
• W2012256930 cites W4235505771 @default.
• W2012256930 cites W4242179516 @default.
• W2012256930 cites W4250314411 @default.
• W2012256930 cites W4254867956 @default.
• W2012256930 cites W4255423160 @default.
• W2012256930 cites W4255533032 @default.
• W2012256930 cites W4256073489 @default.
• W2012256930 cites W4293247451 @default.
• W2012256930 cites W63938293 @default.
• W2012256930 doi "https://doi.org/10.1359/jbmr.2002.17.6.979" @default.
• W2012256930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12054173" @default.
• W2012256930 hasPublicationYear "2002" @default.
• W2012256930 type Work @default.
• W2012256930 sameAs 2012256930 @default.
• W2012256930 citedByCount "185" @default.
• W2012256930 countsByYear W20122569302012 @default.
• W2012256930 countsByYear W20122569302013 @default.
• W2012256930 countsByYear W20122569302014 @default.
• W2012256930 countsByYear W20122569302015 @default.
• W2012256930 countsByYear W20122569302016 @default.
• W2012256930 countsByYear W20122569302017 @default.
• W2012256930 countsByYear W20122569302018 @default.
• W2012256930 countsByYear W20122569302019 @default.
• W2012256930 countsByYear W20122569302020 @default.
• W2012256930 countsByYear W20122569302021 @default.
• W2012256930 countsByYear W20122569302022 @default.
• W2012256930 countsByYear W20122569302023 @default.
• W2012256930 crossrefType "journal-article" @default.
• W2012256930 hasAuthorship W2012256930A5030709787 @default.
• W2012256930 hasAuthorship W2012256930A5034358714 @default.
• W2012256930 hasAuthorship W2012256930A5039317852 @default.
• W2012256930 hasAuthorship W2012256930A5049986054 @default.
• W2012256930 hasAuthorship W2012256930A5050877182 @default.
• W2012256930 hasAuthorship W2012256930A5055574817 @default.
• W2012256930 hasConcept C126322002 @default.
• W2012256930 hasConcept C134018914 @default.
• W2012256930 hasConcept C166075782 @default.
• W2012256930 hasConcept C181199279 @default.
• W2012256930 hasConcept C185592680 @default.
• W2012256930 hasConcept C2776317432 @default.
• W2012256930 hasConcept C2780401358 @default.
• W2012256930 hasConcept C2780484280 @default.
• W2012256930 hasConcept C2780841215 @default.
• W2012256930 hasConcept C54009773 @default.
• W2012256930 hasConcept C54355233 @default.
• W2012256930 hasConcept C55493867 @default.
• W2012256930 hasConcept C59493245 @default.
• W2012256930 hasConcept C71924100 @default.
• W2012256930 hasConcept C81885089 @default.
• W2012256930 hasConcept C86803240 @default.
• W2012256930 hasConceptScore W2012256930C126322002 @default.
• W2012256930 hasConceptScore W2012256930C134018914 @default.
• W2012256930 hasConceptScore W2012256930C166075782 @default.
• W2012256930 hasConceptScore W2012256930C181199279 @default.

• next